By expenditures
| Name | Title | Type |
|---|---|---|
| Joe Barker | Chief School Business Official | Auditee |
| David Jelonek | Partner | Auditee |
| John Wysocki | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 353840 | 2024 | 2025-04-16 | Gw & Associates PC | $13.93M |
| 317421 | 2023 | 2024-08-19 | Gw & Associates PC | $12.38M |
| 54227 | 2022 | 2023-05-14 | Gw & Associates PC | $20.21M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 353840 | 2024 | 2025-04-16 | 1131672 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 1131671 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 1131670 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 1131669 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 1131668 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 1131667 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 1131666 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 1131665 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 555230 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 555229 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 555228 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 555227 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 555226 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 555225 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 555224 | 2024-004 | Significant Deficiency | - | ABL |
| 353840 | 2024 | 2025-04-16 | 555223 | 2024-004 | Significant Deficiency | - | ABL |
| 317421 | 2023 | 2024-08-19 | 1057840 | 2023-003 | Significant Deficiency | - | ABL |
| 317421 | 2023 | 2024-08-19 | 1057839 | 2023-003 | Significant Deficiency | - | ABL |
| 317421 | 2023 | 2024-08-19 | 1057838 | 2023-003 | Significant Deficiency | - | ABL |
| 317421 | 2023 | 2024-08-19 | 1057837 | 2023-003 | Significant Deficiency | - | ABL |
| 317421 | 2023 | 2024-08-19 | 481398 | 2023-003 | Significant Deficiency | - | ABL |
| 317421 | 2023 | 2024-08-19 | 481397 | 2023-003 | Significant Deficiency | - | ABL |
| 317421 | 2023 | 2024-08-19 | 481396 | 2023-003 | Significant Deficiency | - | ABL |
| 317421 | 2023 | 2024-08-19 | 481395 | 2023-003 | Significant Deficiency | - | ABL |